Modern Poultry Media

Category: Merck Animal Health

Merck Animal Health launches experimental autogenous vaccine for avian metapneumovirus type B

Merck Animal Health reports that the USDA has approved the manufacturing and sale of Cambridge Technologies’ experimental autogenous vaccine in the US for the emerging and deadly avian metapneumovirus type B, impacting broilers, broiler breeders, layers and turkey breeders. 

More from Merck Animal Health

Modern Poultry is pleased to host
this editorial page on behalf of

Merck Animal Health